))
Episode #6 - Funding for Rare Disorders and COVID-19
Manage episode 294471722 series 2937012
Content provided by Connex Health Consulting. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Connex Health Consulting or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Featuring Durhane Wong-Rieger, PhD, President & CEO, Canadian Organization for Rare Disorders (CORD).In this episode we have the pleasure of speaking with Durhane Wong-Rieger and exploring rare disorders in a world struggling to cope with COVID-19. Durhane explains the important role of CORD in advocating on behalf of rare disorders. She also speaks to the definition of a rare disorder and the number of individuals diagnosed in Canada. Plus we explore the difference between a drug for a rare disorder and an orphan drug as well as their cost and the public/private split for funding of these drugs.Finally, Durhane gives us an update on the creation of a national strategy to fund drugs for rare disorders and diseases, the challenges of our current environment, particularly the impact of COVID-19, and to what extent a national strategy is likely to reduce pressure on private drug plans.Recorded June 26, 2020.Find out more information on upcoming podcasts and webinars at https://connexhc.com
…
continue reading
41 episodes
Share
